Doctors warn cold wave increases infection risks, strains cardiovascular health, and highlights the importance of hydration ...
Patients with SARD-ILD-PPF who continued nintedanib for 12 months or longer had better outcomes than those who discontinued therapy.
Medical Device Network on MSN
CSA Medical submits application to FDA for RejuvenAir System
The system aims to address underlying chronic cough and issues with mucus production and clearance in chronic bronchitis.
3 Department of Frontier Cardiovascular Science, Graduate School of Medicine, the University of Tokyo, Tokyo, Japan Correspondence to Dr Shun Minatsuki, The University of Tokyo, Bunkyo-ku 113-0033, ...
The first COPD patient has been dosed in a Phase 1b COPD trial testing Bambusa Therapeutics’ dual-target therapy BBT002.
CSA Medical, Inc., a medical device company focused on interventional pulmonary therapies, today announced the submission of ...
GlaxoSmithKline’s (GSK) Nucala (mepolizumab) has been approved by the MHRA to treat adults with uncontrolled chronic ...
Mount Sinai analysis looks at the effectiveness of electrocardiograms analyzed via deep learning as a tool for early COPD detection ...
Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality globally. Effective management ...
A new development in wireless sensing technology which can reliably screen for five common pulmonary diseases could lead to breakthrough new forms of touch-free diagnostics.
An inquest has opened into the death of a man who died after waiting almost 40 minutes for an ambulance while struggling to ...
AI and wireless sensing detect five common lung diseases touch-free, enabling early, personalised health monitoring.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback